Global Dental Bone Graft Substitutes Market Size (2024 - 2029)

The dental bone graft substitutes market is anticipated to experience growth over the forecast period, driven by factors such as the increasing demand for medical and dental tourism, the rising burden of dental diseases, and technological advancements in dentistry. The market's expansion is further supported by the growing use of synthetic and biocompatible grafts in dental procedures, which are essential for successful implant surgeries. Strategic initiatives by market players also contribute to the market's growth. However, the high cost of dental procedures and reimbursement challenges pose obstacles to market expansion.

Market Size of Global Dental Bone Graft Substitutes Industry

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:
Dental Bone Graft Substitutes Market Summary
Study Period 2019 - 2029
Base Year For Estimation 2023
CAGR 6.80 %
Fastest Growing Market Asia-Pacific
Largest Market North America
Market Concentration Medium

Major Players

Dental Bone Graft Substitutes Market Major Players

*Disclaimer: Major Players sorted in no particular order

setting-icon

Need a report that reflects how COVID-19 has impacted this market and its growth?

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Dental Bone Graft Substitutes Market Analysis

The dental bone graft substitutes market is expected to witness a CAGR of 6.8% over the forecast period, 2022-2027.

The COVID-19 pandemic has impacted industries worldwide. As all healthcare providers were engaged with COVID-19 management, access was restricted to essential care only, and the temporary closure of dental clinics drastically reduced dental surgeries. For instance, the American Dental Association (ADA) recommended that elective dental procedures be postponed until April 6, 2020, and dental practices should provide emergency-only dental services. Additionally, as per April 1, 2020, update, the ADA advised offices to remain closed to all but urgent and emergency procedures until April 30, at the earliest, owing to increasing COVID-19 cases. As a result, access to dental care was substantially decreased. Moreover, in March 2020, an ADA health policy institute survey indicated that 76% of dental offices surveyed were closed but seeing emergency patients only, 19% were completely closed, and 5% were open but seeing a lower volume of patients. These factors severely impacted dental bone graft substitute manufacturers and their supply chains. Thus, these statistics indicate that the demand for dental bone graft substitutes was reduced during the COVID-19 pandemic.

Furthermore, the significant factors responsible for the market's growth include the rising demand for medical and dental tourism; the increasing burden of dental diseases; and technological advancements in dentistry. The rising burden of dental diseases is driving the market's growth. For instance, according to the World Health Organization (2020), oral diseases affect nearly 3.5 billion people, and over 530 million children suffer from caries of their primary teeth.

To maintain the existing jaw, bone grafting is done before implant placement, which helps with successful implant surgery. Thus, increasing the use of such synthetic and biocompatible grafts in dental procedures ultimately triggers the market's growth. As per a May 2020 published study titled "Global Prevalence of Periodontal Disease and Lack of Its Surveillance," periodontitis was most common in older people and populations from high-income countries. The distribution varied significantly between low-income (28.7%), lower-middle (10%), upper-middle (42.5%), and high-income (43.7%) countries. Additionally, according to the International Dental Journal's article titled, "Risk Indicators of Tooth Loss among the Mexican Adult Population: A Cross-Sectional Study," published in February 2021, tooth loss was 57.2% due to tooth decay in Mexico. Hence, owing to the aforementioned factors, the market is expected to witness significant growth in the future.

Additionally, the strategic initiatives taken by the market players are also propelling the growth of the market. For instance, in April 2022, the Aspen Group and ACE Surgical Supply, one of the providers of bone regenerative products, signed a multi-year strategic partnership for dental bone grafting solutions.

Thus, owing to the abovementioned factors, the market is expected to show growth over the forecast period. However, expensive dental procedures and reimbursement issues hinder the market's growth.

Dental Bone Graft Substitutes Industry Segmentation

As per the scope of this report, a bone graft is used to fix problematic joints or damaged ones, which helps grow bone around the implant. Bone grafting is performed before dental implants to restore missing teeth. Moreover, dentistry uses bone grafts as fillers and scaffolds to facilitate bone formation and promote wound healing. They have no antigen-antibody reaction and are biodegradable. The dental bone grafts develop a new bone that acts as a mineral reservoir. The dental bone graft substitutes market is segmented by product type (xenograft, allograft, autograft, and other types), the mechanism (osteoconduction, osteoinduction, osteogenesis, and osteopromotion), end users (hospitals, dental clinics, and other end users), and geography (North America, Europe, Asia Pacific, Middle East and Africa, and South America). The report also covers the estimated market sizes and trends for 17 countries across significant global regions. The report offers the value (USD million) for the above segments.

By Type
Xenograft
Allograft
Autograft
Other Types
By Mechanism
Osteoconduction
Osteoinduction
Osteogenesis
Osteopromotion
By End Users
Hospitals
Dental Clinics
Other End Users
Geography
North America
United States
Canada
Mexico
Europe
Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle-East and Africa
GCC
South Africa
Rest of Middle-East and Africa
South America
Brazil
Argentina
Rest of South America
Need A Different Region Or Segment?
Customize Now

Global Dental Bone Graft Substitutes Market Size Summary

The dental bone graft substitutes market is poised for significant growth, driven by increasing demand for dental procedures and advancements in dental technology. The market experienced a temporary setback due to the COVID-19 pandemic, which led to the postponement of elective dental surgeries and restricted access to dental care. However, the market is rebounding as the demand for dental tourism and the prevalence of dental diseases rise. The use of synthetic and biocompatible grafts in dental procedures is becoming more common, supporting the market's expansion. Strategic partnerships and product launches by key players are further propelling market growth, despite challenges such as high costs and reimbursement issues.

The xenograft segment is expected to hold a substantial share of the market, with affordability being a key factor in its growth. Developments in xenograft products, such as those by Fredun Pharmaceuticals Limited and strategic agreements like the one between Neoss and Purgo Biologics, are anticipated to enhance the segment's market presence. North America, particularly the United States, is expected to dominate the market due to a high number of dental visits and strategic initiatives by market players. The competitive landscape is characterized by the presence of major players like Dentsply Sirona and Johnson & Johnson, with ongoing collaborations and product innovations expected to drive further growth in the market.

Explore More

Global Dental Bone Graft Substitutes Market Size - Table of Contents

  1. 1. MARKET DYNAMICS

    1. 1.1 Market Overview

    2. 1.2 Market Drivers

      1. 1.2.1 Rising Demand of Medical and Dental Tourism

      2. 1.2.2 Rising Burden of Dental Diseases

      3. 1.2.3 Technological Advancements

    3. 1.3 Market Restraints

      1. 1.3.1 Expensive Dental Procedures

      2. 1.3.2 Reimbursement Issues

    4. 1.4 Industry Attractiveness - Porter's Five Forces Analysis

      1. 1.4.1 Bargaining Power of Buyers/Consumers

      2. 1.4.2 Bargaining Power of Suppliers

      3. 1.4.3 Threat of New Entrants

      4. 1.4.4 Threat of Substitute Products

      5. 1.4.5 Intensity of Competitive Rivalry

  2. 2. MARKET SEGMENTATION (Market Size by Value - USD million)

    1. 2.1 By Type

      1. 2.1.1 Xenograft

      2. 2.1.2 Allograft

      3. 2.1.3 Autograft

      4. 2.1.4 Other Types

    2. 2.2 By Mechanism

      1. 2.2.1 Osteoconduction

      2. 2.2.2 Osteoinduction

      3. 2.2.3 Osteogenesis

      4. 2.2.4 Osteopromotion

    3. 2.3 By End Users

      1. 2.3.1 Hospitals

      2. 2.3.2 Dental Clinics

      3. 2.3.3 Other End Users

    4. 2.4 Geography

      1. 2.4.1 North America

        1. 2.4.1.1 United States

        2. 2.4.1.2 Canada

        3. 2.4.1.3 Mexico

      2. 2.4.2 Europe

        1. 2.4.2.1 Germany

        2. 2.4.2.2 United Kingdom

        3. 2.4.2.3 France

        4. 2.4.2.4 Italy

        5. 2.4.2.5 Spain

        6. 2.4.2.6 Rest of Europe

      3. 2.4.3 Asia-Pacific

        1. 2.4.3.1 China

        2. 2.4.3.2 Japan

        3. 2.4.3.3 India

        4. 2.4.3.4 Australia

        5. 2.4.3.5 South Korea

        6. 2.4.3.6 Rest of Asia-Pacific

      4. 2.4.4 Middle-East and Africa

        1. 2.4.4.1 GCC

        2. 2.4.4.2 South Africa

        3. 2.4.4.3 Rest of Middle-East and Africa

      5. 2.4.5 South America

        1. 2.4.5.1 Brazil

        2. 2.4.5.2 Argentina

        3. 2.4.5.3 Rest of South America

Global Dental Bone Graft Substitutes Market Size FAQs

The Global Dental Bone Graft Substitutes Market is projected to register a CAGR of 6.80% during the forecast period (2024-2029)

Johnson & Johnson, Institut Straumann AG, Medtronic PLC, Dentsply Sirona and ZimVie Inc are the major companies operating in the Global Dental Bone Graft Substitutes Market.

Dental Bone Graft Substitutes Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)